메뉴 건너뛰기




Volumn 28, Issue 10, 2010, Pages 1983-1994

Microalbuminuria as a risk factor: The influence of renin-angiotensin system blockade

Author keywords

angiotensin II receptor blockers; cardiovascular disease; diabetes; microalbuminuria; renal disease; reninangiotensin system

Indexed keywords

ALBUMIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; GLICLAZIDE; INDAPAMIDE PLUS PERINDOPRIL; IRBESARTAN; LISINOPRIL; LOSARTAN; OLMESARTAN; PRAVASTATIN; RAMIPRIL; TELMISARTAN; TRANDOLAPRIL; VERAPAMIL;

EID: 77957256321     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833c206d     Document Type: Review
Times cited : (30)

References (98)
  • 1
    • 0021322084 scopus 로고
    • Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes
    • Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310:356-360.
    • (1984) N Engl J Med , vol.310 , pp. 356-360
    • Mogensen, C.E.1
  • 2
    • 0020045025 scopus 로고
    • Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus
    • Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1:1430-1432.
    • (1982) Lancet , vol.1 , pp. 1430-1432
    • Viberti, G.C.1    Hill, R.D.2    Jarrett, R.J.3    Argyropoulos, A.4    Mahmud, U.5    Keen, H.6
  • 3
    • 34447309619 scopus 로고    scopus 로고
    • Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)
    • Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007; 116:151-157.
    • (2007) Circulation , vol.116 , pp. 151-157
    • Barr, E.L.1    Zimmet, P.Z.2    Welborn, T.A.3    Jolley, D.4    Magliano, D.J.5    Dunstan, D.W.6
  • 4
    • 34250376089 scopus 로고    scopus 로고
    • Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease
    • Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med 2007; 167:1145-1151.
    • (2007) Arch Intern Med , vol.167 , pp. 1145-1151
    • Franco, O.H.1    Steyerberg, E.W.2    Hu, F.B.3    MacKenbach, J.4    Nusselder, W.5
  • 7
    • 11844259382 scopus 로고    scopus 로고
    • Standards of medical care in diabetes
    • American Diabetic Association. Standards of medical care in diabetes. Diabetes Care 2005; 28 (Suppl 1):S4-S36.
    • (2005) Diabetes Care , vol.28 , Issue.SUPPL. 1
  • 8
    • 33845434334 scopus 로고    scopus 로고
    • Reevaluation by high-performance liquid chromatography: Clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study
    • McQueen MJ, Gerstein HC, Pogue J, Mann JF, Yusuf S. Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study. Am J Kidney Dis 2006; 48:889-896.
    • (2006) Am J Kidney Dis , vol.48 , pp. 889-896
    • McQueen, M.J.1    Gerstein, H.C.2    Pogue, J.3    Mann, J.F.4    Yusuf, S.5
  • 9
    • 20244378912 scopus 로고    scopus 로고
    • Which test to detect microalbuminuria in diabetic patients? A systematic review
    • 571
    • Ewald B, Attia J. Which test to detect microalbuminuria in diabetic patients? A systematic review. Aust Fam Physician 2004; 33:565-567; 571.
    • (2004) Aust Fam Physician , vol.33 , pp. 565-567
    • Ewald, B.1    Attia, J.2
  • 10
    • 53749086716 scopus 로고    scopus 로고
    • For the PREVEND Study Group. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality
    • Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, Bakker SJL, de Jong PE, Gansevoort RT, for the PREVEND Study Group. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 2008; 168:897-905.
    • (2008) Am J Epidemiol , vol.168 , pp. 897-905
    • Lambers Heerspink, H.J.1    Brantsma, A.H.2    De Zeeuw, D.3    Sjl, B.4    De Jong, P.E.5    Gansevoort, R.T.6
  • 12
    • 0037820396 scopus 로고    scopus 로고
    • Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes
    • Mogensen CE. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med 2003; 254:45-66.
    • (2003) J Intern Med , vol.254 , pp. 45-66
    • Mogensen, C.E.1
  • 13
    • 33646771273 scopus 로고    scopus 로고
    • Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective
    • Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006; 69:2057-2063.
    • (2006) Kidney Int , vol.69 , pp. 2057-2063
    • Parving, H.H.1    Lewis, J.B.2    Ravid, M.3    Remuzzi, G.4    Hunsicker, L.G.5
  • 15
    • 7444256617 scopus 로고    scopus 로고
    • Albuminuria is evident in the early stages of diabetes onset: Results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)
    • Tapp RJ, Shaw JE, Zimmet PZ, Balkau B, Chadban SJ, Tonkin AM, et al. Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis 2004; 44:792-798.
    • (2004) Am J Kidney Dis , vol.44 , pp. 792-798
    • Tapp, R.J.1    Shaw, J.E.2    Zimmet, P.Z.3    Balkau, B.4    Chadban, S.J.5    Tonkin, A.M.6
  • 16
    • 21644445444 scopus 로고    scopus 로고
    • Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: The pathways study
    • Young BA, Katon WJ, Von Korff M, Simon GE, Lin EH, Ciechanowski PS, et al. Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study. J Am Soc Nephrol 2005; 16:219-228.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 219-228
    • Young, B.A.1    Katon, W.J.2    Von Korff, M.3    Simon, G.E.4    Lin, E.H.5    Ciechanowski, P.S.6
  • 17
    • 12944302104 scopus 로고    scopus 로고
    • An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: The MicroAlbuminuria Prevalence (MAP) Study
    • Wu AY, Kong NC, de Leon FA, Pan CY, Tai TY, Yeung VT, et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 2005; 48:17-26.
    • (2005) Diabetologia , vol.48 , pp. 17-26
    • Wu, A.Y.1    Kong, N.C.2    De Leon, F.A.3    Pan, C.Y.4    Tai, T.Y.5    Yeung, V.T.6
  • 18
    • 0034852962 scopus 로고    scopus 로고
    • Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity
    • Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001; 249:519-526.
    • (2001) J Intern Med , vol.249 , pp. 519-526
    • Hillege, H.L.1    Janssen, W.M.2    Bak, A.A.3    Diercks, G.F.4    Grobbee, D.E.5    Crijns, H.J.6
  • 19
    • 0036482589 scopus 로고    scopus 로고
    • Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study. Losartan Intervention for Endpoint Reduction
    • Wachtell K, Palmieri V, Olsen MH, Bella JN, Aalto T, Dahlof B, et al. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 2002; 143:319-326.
    • (2002) Am Heart J , vol.143 , pp. 319-326
    • Wachtell, K.1    Palmieri, V.2    Olsen, M.H.3    Bella, J.N.4    Aalto, T.5    Dahlof, B.6
  • 21
    • 33746473003 scopus 로고    scopus 로고
    • Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms
    • Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 2006; 17:2106-2111.
    • (2006) J Am Soc Nephrol , vol.17 , pp. 2106-2111
    • Stehouwer, C.D.1    Smulders, Y.M.2
  • 22
    • 40449103790 scopus 로고    scopus 로고
    • Albuminuria, but not estimated glomerular filtration rate, is associated with maladaptive arterial remodeling: The Hoorn Study
    • Hermans MM, Henry RM, Dekker JM, Nijpels G, Heine RJ, Stehouwer CD. Albuminuria, but not estimated glomerular filtration rate, is associated with maladaptive arterial remodeling: the Hoorn Study. J Hypertens 2008; 26:791-797.
    • (2008) J Hypertens , vol.26 , pp. 791-797
    • Hermans, M.M.1    Henry, R.M.2    Dekker, J.M.3    Nijpels, G.4    Heine, R.J.5    Stehouwer, C.D.6
  • 23
    • 33646794442 scopus 로고    scopus 로고
    • Microalbuminuria as a target to improve cardiovascular and renal outcomes
    • Basi S, Lewis JB. Microalbuminuria as a target to improve cardiovascular and renal outcomes. Am J Kidney Dis 2006; 47:927-946.
    • (2006) Am J Kidney Dis , vol.47 , pp. 927-946
    • Basi, S.1    Lewis, J.B.2
  • 24
    • 33845523712 scopus 로고    scopus 로고
    • Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: An IRMA 2 substudy
    • Persson F, Rossing P, Hovind P, Stehouwer CD, Schalkwijk C, Tarnow L, et al. Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy. Diabetes 2006; 55:3550-3555.
    • (2006) Diabetes , vol.55 , pp. 3550-3555
    • Persson, F.1    Rossing, P.2    Hovind, P.3    Stehouwer, C.D.4    Schalkwijk, C.5    Tarnow, L.6
  • 25
    • 0035922444 scopus 로고    scopus 로고
    • The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
    • Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345:870-878.
    • (2001) N Engl J Med , vol.345 , pp. 870-878
    • Parving, H.H.1    Lehnert, H.2    Brochner-Mortensen, J.3    Gomis, R.4    Andersen, S.5    Arner, P.6
  • 26
    • 36048929086 scopus 로고    scopus 로고
    • Macroalbuminuria and microalbuminuria: Do both predict renal and cardiovascular events with similar strength?
    • de Jong PE, Gansevoort RT, Bakker SJ. Macroalbuminuria and microalbuminuria: do both predict renal and cardiovascular events with similar strength? J Nephrol 2007; 20:375-380.
    • (2007) J Nephrol , vol.20 , pp. 375-380
    • De Jong, P.E.1    Gansevoort, R.T.2    Bakker, S.J.3
  • 27
    • 34748862301 scopus 로고    scopus 로고
    • Microalbuminuria and cardiovascular disease
    • Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007; 2:581-590.
    • (2007) Clin J Am Soc Nephrol , vol.2 , pp. 581-590
    • Weir, M.R.1
  • 28
    • 1242329243 scopus 로고    scopus 로고
    • Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: A temporal perspective
    • Lane JT. Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective. Am J Physiol Renal Physiol 2004; 286:F442-450.
    • (2004) Am J Physiol Renal Physiol , vol.286
    • Lane, J.T.1
  • 29
    • 7444241997 scopus 로고    scopus 로고
    • Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan
    • Iseki K, Kinjo K, Iseki C, Takishita S. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis 2004; 44:806-814.
    • (2004) Am J Kidney Dis , vol.44 , pp. 806-814
    • Iseki, K.1    Kinjo, K.2    Iseki, C.3    Takishita, S.4
  • 30
    • 33646343461 scopus 로고    scopus 로고
    • Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the Multiple Risk Factor Intervention Trial
    • Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, et al. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the Multiple Risk Factor Intervention Trial. J Am Soc Nephrol 2006; 17:1444-1452.
    • (2006) J Am Soc Nephrol , vol.17 , pp. 1444-1452
    • Ishani, A.1    Grandits, G.A.2    Grimm, R.H.3    Svendsen, K.H.4    Collins, A.J.5    Prineas, R.J.6
  • 31
    • 33947529409 scopus 로고    scopus 로고
    • Clinical utility of trace proteinuria for microalbuminuria screening in the general population
    • KontaT, Hao Z, Takasaki S, Abiko H, Ishikawa M, Takahashi T, et al. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol 2007; 11:51-55.
    • (2007) Clin Exp Nephrol , vol.11 , pp. 51-55
    • Kontat Hao, Z.1    Takasaki, S.2    Abiko, H.3    Ishikawa, M.4    Takahashi, T.5
  • 34
    • 62149146456 scopus 로고    scopus 로고
    • The case for using albuminuria in staging chronic kidney disease
    • Gansevoort RT, de Jong PE. The case for using albuminuria in staging chronic kidney disease. J Am Soc Nephrol 2009; 20:465-468.
    • (2009) J Am Soc Nephrol , vol.20 , pp. 465-468
    • Gansevoort, R.T.1    De Jong, P.E.2
  • 35
    • 0029906706 scopus 로고    scopus 로고
    • Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin e in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation
    • Gerstein HC, Bosch J, Pogue J, Taylor DW, Zinman B, Yusuf S. Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation. Diabetes Care 1 996; 19:1225-1228.
    • Diabetes Care , vol.996 , Issue.19 , pp. 1225-1228
    • Gerstein, H.C.1    Bosch, J.2    Pogue, J.3    Taylor, D.W.4    Zinman, B.5    Yusuf, S.6
  • 36
    • 0035948631 scopus 로고    scopus 로고
    • Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals
    • Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286:421-426.
    • (2001) JAMA , vol.286 , pp. 421-426
    • Gerstein, H.C.1    Mann, J.F.2    Yi, Q.3    Zinman, B.4    Dinneen, S.F.5    Hoogwerf, B.6
  • 37
    • 33748948399 scopus 로고    scopus 로고
    • Time to abandon microalbuminuria?
    • Ruggenenti P, Remuzzi G. Time to abandon microalbuminuria? Kidney Int 2006; 70:1214-1222.
    • (2006) Kidney Int , vol.70 , pp. 1214-1222
    • Ruggenenti, P.1    Remuzzi, G.2
  • 38
    • 46449117134 scopus 로고    scopus 로고
    • Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: The nordic diltiazem study
    • Farbom P, Wahlstrand B, Almgren P, Skrtic S, Lanke J, Weiss L, et al. Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: the nordic diltiazem study. Hypertension 2008; 52:115-122.
    • (2008) Hypertension , vol.52 , pp. 115-122
    • Farbom, P.1    Wahlstrand, B.2    Almgren, P.3    Skrtic, S.4    Lanke, J.5    Weiss, L.6
  • 39
    • 0036788492 scopus 로고    scopus 로고
    • Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population
    • Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106:1777-1782.
    • (2002) Circulation , vol.106 , pp. 1777-1782
    • Hillege, H.L.1    Fidler, V.2    Diercks, G.F.3    Van Gilst, W.H.4    De Zeeuw, D.5    Van Veldhuisen, D.J.6
  • 40
    • 23844491509 scopus 로고    scopus 로고
    • Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: The Framingham Heart Study
    • Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112:969-975.
    • (2005) Circulation , vol.112 , pp. 969-975
    • Arnlov, J.1    Evans, J.C.2    Meigs, J.B.3    Wang, T.J.4    Fox, C.S.5    Levy, D.6
  • 41
    • 55949127699 scopus 로고    scopus 로고
    • The relationship between proteinuria and coronary risk: A systematic review and meta-analysis
    • Perkovic V, Verdon C, Ninomiya T, Barzi F, Cass A, Patel A, et al. The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med 2008; 5:e207.
    • (2008) PLoS Med , vol.5
    • Perkovic, V.1    Verdon, C.2    Ninomiya, T.3    Barzi, F.4    Cass, A.5    Patel, A.6
  • 43
    • 15444362609 scopus 로고    scopus 로고
    • Low-grade albuminuria and the risks of hypertension and blood pressure progression
    • Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D'Agostino RB, et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005; 111:1370-1376.
    • (2005) Circulation , vol.111 , pp. 1370-1376
    • Wang, T.J.1    Evans, J.C.2    Meigs, J.B.3    Rifai, N.4    Fox, C.S.5    D'Agostino, R.B.6
  • 44
    • 25644432841 scopus 로고    scopus 로고
    • Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes
    • Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 2005; 28:2525-2530.
    • (2005) Diabetes Care , vol.28 , pp. 2525-2530
    • Brantsma, A.H.1    Bakker, S.J.2    Hillege, H.L.3    De Zeeuw, D.4    De Jong, P.E.5    Gansevoort, R.T.6
  • 45
    • 54049143675 scopus 로고    scopus 로고
    • Higher levels of albuminuria within the normal range predict incident hypertension
    • Forman JP, Fisher ND, Schopick EL, Curhan GC. Higher levels of albuminuria within the normal range predict incident hypertension. J Am Soc Nephrol 2008; 19:1983-1988.
    • (2008) J Am Soc Nephrol , vol.19 , pp. 1983-1988
    • Forman, J.P.1    Fisher, N.D.2    Schopick, E.L.3    Curhan, G.C.4
  • 47
    • 0030780566 scopus 로고    scopus 로고
    • Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality
    • Berton G, Citro T, Palmieri R, Petucco S, De Toni R, Palatini P. Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality. Circulation 1997; 96:3338-3345.
    • (1997) Circulation , vol.96 , pp. 3338-3345
    • Berton, G.1    Citro, T.2    Palmieri, R.3    Petucco, S.4    De Toni, R.5    Palatini, P.6
  • 48
    • 19344362879 scopus 로고    scopus 로고
    • Microalbuminuria: A strong predictor of 3-year adverse prognosis in nondiabetic patients with acute myocardial infarction
    • KoulourisS, Lekatsas I, Karabinos I, IoannidisG, KatostarasT, Kranidis A, et al. Microalbuminuria: a strong predictor of 3-year adverse prognosis in nondiabetic patients with acute myocardial infarction. Am Heart J 2005; 149:840-845.
    • (2005) Am Heart J , vol.149 , pp. 840-845
    • Koulouris, S.1    Lekatsas, I.2    Karabinos, I.3    Katostarast, I.4    Kranidis, A.5
  • 49
    • 0034882169 scopus 로고    scopus 로고
    • Microalbuminuria during acute myocardial infarction; A strong predictor for 1-year mortality
    • Berton G, Cordiano R, Palmieri R, Cucchini F, De Toni R, Palatini P. Microalbuminuria during acute myocardial infarction; a strong predictor for 1-year mortality. Eur Heart J 2001; 22:1466-1475.
    • (2001) Eur Heart J , vol.22 , pp. 1466-1475
    • Berton, G.1    Cordiano, R.2    Palmieri, R.3    Cucchini, F.4    De Toni, R.5    Palatini, P.6
  • 50
    • 5644295547 scopus 로고    scopus 로고
    • Albumin excretion in diabetic patients in the setting of acute myocardial infarction: Association with 3-year mortality
    • Berton G, Cordiano R, Palmieri R, De Toni R, Guarnieri GL, Palatini P. Albumin excretion in diabetic patients in the setting of acute myocardial infarction: association with 3-year mortality. Diabetologia 2004; 47:1511-1518.
    • (2004) Diabetologia , vol.47 , pp. 1511-1518
    • Berton, G.1    Cordiano, R.2    Palmieri, R.3    De Toni, R.4    Guarnieri, G.L.5    Palatini, P.6
  • 51
    • 52949146300 scopus 로고    scopus 로고
    • Albumin excretion in acute myocardial infarction: A guide for long-term prognosis
    • Berton G, Cordiano R, Mazzuco S, Katz E, De Toni R, Palatini P. Albumin excretion in acute myocardial infarction: a guide for long-term prognosis. Am Heart J 2008; 156:760-768.
    • (2008) Am Heart J , vol.156 , pp. 760-768
    • Berton, G.1    Cordiano, R.2    Mazzuco, S.3    Katz, E.4    De Toni, R.5    Palatini, P.6
  • 52
    • 33745953625 scopus 로고    scopus 로고
    • Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus
    • Sukhija R, Aronow WS, Kakar P, Garza L, Sachdeva R, Sinha A, et al. Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus. Am J Cardiol 2006; 98:279-281.
    • (2006) Am J Cardiol , vol.98 , pp. 279-281
    • Sukhija, R.1    Aronow, W.S.2    Kakar, P.3    Garza, L.4    Sachdeva, R.5    Sinha, A.6
  • 54
    • 3042856282 scopus 로고    scopus 로고
    • Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes
    • Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 110:32-35.
    • (2004) Circulation , vol.110 , pp. 32-35
    • Klausen, K.1    Borch-Johnsen, K.2    Feldt-Rasmussen, B.3    Jensen, G.4    Clausen, P.5    Scharling, H.6
  • 55
    • 0037804204 scopus 로고    scopus 로고
    • Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension
    • Leoncini G, Viazzi F, Parodi D, Vettoretti S, Ratto E, Ravera M, et al. Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension 2003; 42:14-18.
    • (2003) Hypertension , vol.42 , pp. 14-18
    • Leoncini, G.1    Viazzi, F.2    Parodi, D.3    Vettoretti, S.4    Ratto, E.5    Ravera, M.6
  • 56
    • 34548858445 scopus 로고    scopus 로고
    • Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension
    • Salles GF, Fiszman R, Cardoso CR, Muxfeldt ES. Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension. Hypertension 2007; 50:723-728.
    • (2007) Hypertension , vol.50 , pp. 723-728
    • Salles, G.F.1    Fiszman, R.2    Cardoso, C.R.3    Muxfeldt, E.S.4
  • 57
    • 0141446280 scopus 로고    scopus 로고
    • Relation of leftventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: The strong heart study
    • Palmieri V, Tracy RP, Roman MJ, Liu JE, Best LG, Bella JN, et al. Relation of leftventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study. Diabetes Care 2003; 26:2764-2769.
    • (2003) Diabetes Care , vol.26 , pp. 2764-2769
    • Palmieri, V.1    Tracy, R.P.2    Roman, M.J.3    Liu, J.E.4    Best, L.G.5    Bella, J.N.6
  • 58
    • 0031023772 scopus 로고    scopus 로고
    • A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study
    • Nakayama T, Date C, Yokoyama T, Yoshiike N, Yamaguchi M, Tanaka H. A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study. Stroke 1997; 28:45-52.
    • (1997) Stroke , vol.28 , pp. 45-52
    • Nakayama, T.1    Date, C.2    Yokoyama, T.3    Yoshiike, N.4    Yamaguchi, M.5    Tanaka, H.6
  • 59
    • 1242340400 scopus 로고    scopus 로고
    • Microalbuminuria and stroke in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study
    • Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, et al. Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. J Intern Med 2004; 255:247-256.
    • (2004) J Intern Med , vol.255 , pp. 247-256
    • Yuyun, M.F.1    Khaw, K.T.2    Luben, R.3    Welch, A.4    Bingham, S.5    Day, N.E.6
  • 61
    • 33747445884 scopus 로고    scopus 로고
    • Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases
    • Klausen KP, Scharling H, Jensen JS. Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. J Intern Med 2006; 260:231-237.
    • (2006) J Intern Med , vol.260 , pp. 231-237
    • Klausen, K.P.1    Scharling, H.2    Jensen, J.S.3
  • 63
    • 0037213037 scopus 로고    scopus 로고
    • Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
    • Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63:225-232.
    • (2003) Kidney Int , vol.63 , pp. 225-232
    • Adler, A.I.1    Stevens, R.J.2    Manley, S.E.3    Bilous, R.W.4    Cull, C.A.5    Holman, R.R.6
  • 65
    • 32944464800 scopus 로고    scopus 로고
    • MARPLE Study Group. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: Final results of a prospective long-term study (MARPLE Study)
    • Schrader J, Luders S, Kulschewski A, Hammersen F, Zuchner C, Venneklaas U, et al., MARPLE Study Group. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study). J Hypertens 2006; 24:541-548.
    • (2006) J Hypertens , vol.24 , pp. 541-548
    • Schrader, J.1    Luders, S.2    Kulschewski, A.3    Hammersen, F.4    Zuchner, C.5    Venneklaas, U.6
  • 66
    • 1642535534 scopus 로고    scopus 로고
    • Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE study
    • Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 2003; 139:901-906.
    • (2003) Ann Intern Med , vol.139 , pp. 901-906
    • Wachtell, K.1    Ibsen, H.2    Olsen, M.H.3    Borch-Johnsen, K.4    Lindholm, L.H.5    Mogensen, C.E.6
  • 67
    • 19944432108 scopus 로고    scopus 로고
    • Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study
    • Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 2005; 45:198202.
    • (2005) Hypertension , vol.45 , pp. 198202
    • Ibsen, H.1    Olsen, M.H.2    Wachtell, K.3    Borch-Johnsen, K.4    Lindholm, L.H.5    Mogensen, C.E.6
  • 68
    • 33744990564 scopus 로고    scopus 로고
    • Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? the LIFE study
    • Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study. Diabetes Care 2006; 29:595-600.
    • (2006) Diabetes Care , vol.29 , pp. 595-600
    • Ibsen, H.1    Olsen, M.H.2    Wachtell, K.3    Borch-Johnsen, K.4    Lindholm, L.H.5    Mogensen, C.E.6
  • 70
    • 1042302783 scopus 로고    scopus 로고
    • Standards of medical care in diabetes
    • American Diabetic Association
    • American Diabetic Association. Standards of medical care in diabetes. Diabetes Care 2004; 27 Suppl 1:S15-S35.
    • (2004) Diabetes Care , vol.27 , Issue.SUPPL. 1
  • 71
    • 6344221992 scopus 로고    scopus 로고
    • Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: Systematic review
    • Strippoli GF, Craig M, Deeks JJ, Schena FP, Craig JC. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ 2004; 329:828.
    • (2004) BMJ , vol.329 , pp. 828
    • Strippoli, G.F.1    Craig, M.2    Deeks, J.J.3    Schena, F.P.4    Craig, J.C.5
  • 72
    • 38049139424 scopus 로고    scopus 로고
    • Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease
    • Kunz R, Friedrich C, Wolbers M, Mann JF. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann Intern Med 2008; 148:30-48.
    • (2008) Ann Intern Med , vol.148 , pp. 30-48
    • Kunz, R.1    Friedrich, C.2    Wolbers, M.3    Mann, J.F.4
  • 73
    • 49149087718 scopus 로고    scopus 로고
    • Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial
    • Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 2008; 372:547-553.
    • (2008) Lancet , vol.372 , pp. 547-553
    • Mann, J.F.1    Schmieder, R.E.2    McQueen, M.3    Dyal, L.4    Schumacher, H.5    Pogue, J.6
  • 74
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329:977-986.
    • (1993) N Engl J Med , vol.329 , pp. 977-986
  • 75
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837-853.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 78
    • 67649659279 scopus 로고    scopus 로고
    • Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: Three randomized trials
    • W3-W4
    • Bilous R, Chaturvedi N, Sjolie AK, Fuller J, Klein R, Orchard T, et al. Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials. Ann Intern Med 2009; 151:11 -20; W3-W4.
    • (2009) Ann Intern Med , vol.151 , pp. 11-20
    • Bilous, R.1    Chaturvedi, N.2    Sjolie, A.K.3    Fuller, J.4    Klein, R.5    Orchard, T.6
  • 79
    • 0037373244 scopus 로고    scopus 로고
    • Development of renal disease in people at high cardiovascular risk: Results of the HOPE randomized study
    • Mann JF, Gerstein HC, Yi QL, Lonn EM, Hoogwerf BJ, Rashkow A, et al. Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study. J Am Soc Nephrol 2003; 14:641-647.
    • (2003) J Am Soc Nephrol , vol.14 , pp. 641-647
    • Mann, J.F.1    Gerstein, H.C.2    Yi, Q.L.3    Lonn, E.M.4    Hoogwerf, B.J.5    Rashkow, A.6
  • 82
    • 28844504752 scopus 로고    scopus 로고
    • Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: Systematic review and meta-analysis
    • Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD, et al. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005; 366:2026-2033.
    • (2005) Lancet , vol.366 , pp. 2026-2033
    • Casas, J.P.1    Chua, W.2    Loukogeorgakis, S.3    Vallance, P.4    Smeeth, L.5    Hingorani, A.D.6
  • 83
    • 33845257120 scopus 로고    scopus 로고
    • Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: A post hoc analysis of the BENEDICT trial
    • Ruggenenti P, Perna A, Ganeva M, Ene-Iordache B, Remuzzi G. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial. J Am Soc Nephrol 2006; 17:3472-3481.
    • (2006) J Am Soc Nephrol , vol.17 , pp. 3472-3481
    • Ruggenenti, P.1    Perna, A.2    Ganeva, M.3    Ene-Iordache, B.4    Remuzzi, G.5
  • 85
    • 0030908772 scopus 로고    scopus 로고
    • Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group
    • Chaturvedi N. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group. Lancet 1997; 349:1787-1792.
    • (1997) Lancet , vol.349 , pp. 1787-1792
    • Chaturvedi, N.1
  • 86
    • 72949106696 scopus 로고    scopus 로고
    • In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria
    • Perkins BA, Ficociello LH, Roshan B, Warram JH, Krolewski AS. In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int 2010; 77:57-64.
    • (2010) Kidney Int , vol.77 , pp. 57-64
    • Perkins, B.A.1    Ficociello, L.H.2    Roshan, B.3    Warram, J.H.4    Krolewski, A.S.5
  • 88
    • 33644799462 scopus 로고    scopus 로고
    • Preventing microalbuminuria in patients with diabetes: Rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study
    • Haller H, Viberti GC, Mimran A, Remuzzi G, Rabelink AJ, Ritz E, et al. Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. J Hypertens 2006; 24:403-408.
    • (2006) J Hypertens , vol.24 , pp. 403-408
    • Haller, H.1    Viberti, G.C.2    Mimran, A.3    Remuzzi, G.4    Rabelink, A.J.5    Ritz, E.6
  • 89
    • 0027263426 scopus 로고
    • Risk factors for development of microalbuminuria in insulin dependent diabetic patients: A cohort study. Microalbuminuria Collaborative Study Group, United Kingdom
    • Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Microalbuminuria Collaborative Study Group, United Kingdom. BMJ 1993; 306:1235-1239.
    • (1993) BMJ , vol.306 , pp. 1235-1239
  • 90
    • 0030583755 scopus 로고    scopus 로고
    • Poverty focused assistance: New category of development aid
    • Nelson EA, Yu LM. Poverty focused assistance: new category of development aid. Lancet 1996; 348:1642-1643.
    • (1996) Lancet , vol.348 , pp. 1642-1643
    • Nelson, E.A.1    Yu, L.M.2
  • 91
    • 0027486359 scopus 로고
    • Prediabetic blood pressure predicts urinary albumin excretion after the onset of type 2 (noninsulin-dependent) diabetes mellitus in Pima Indians
    • Nelson RG, Pettitt DJ, Baird HR, Charles MA, Liu QZ, Bennett PH, et al. Prediabetic blood pressure predicts urinary albumin excretion after the onset of type 2 (noninsulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1993; 36:998-1001.
    • (1993) Diabetologia , vol.36 , pp. 998-1001
    • Nelson, R.G.1    Pettitt, D.J.2    Baird, H.R.3    Charles, M.A.4    Liu, Q.Z.5    Bennett, P.H.6
  • 92
    • 0030742020 scopus 로고    scopus 로고
    • 24-h blood pressure and autonomic function is related to albumin excretion within the normoal buminuricrange in IDDM patients
    • Poulsen PL, Ebbehoj E, Hansen KW, Mogensen CE. 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuricrangeinIDDMpatients.Diabetologia1997;40:718-725.
    • (1997) Diabetologia , vol.40 , pp. 718-725
    • Poulsen, P.L.1    Ebbehoj, E.2    Hansen, K.W.3    Mogensen, C.E.4
  • 93
    • 0030030973 scopus 로고    scopus 로고
    • Five-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients
    • Silveiro SP, Friedman R, de Azevedo MJ, Canani LH, Gross JL. Five-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients. Diabetes Care 1996; 19:171-174.
    • (1996) Diabetes Care , vol.19 , pp. 171-174
    • Silveiro, S.P.1    Friedman, R.2    De Azevedo, M.J.3    Canani, L.H.4    Gross, J.L.5
  • 94
    • 0036190137 scopus 로고    scopus 로고
    • Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes
    • Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002; 61:1086-1097.
    • (2002) Kidney Int , vol.61 , pp. 1086-1097
    • Schrier, R.W.1    Estacio, R.O.2    Esler, A.3    Mehler, P.4
  • 95
    • 0029076841 scopus 로고
    • Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group
    • Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. Kidney Int 1995; 47:1703-1720.
    • (1995) Kidney Int , vol.47 , pp. 1703-1720
  • 96
    • 0142087597 scopus 로고    scopus 로고
    • Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study
    • Steffes MW, Chavers BM, Molitch ME, Cleary PA, Lachinc JM, Genuth S, Nathen DM. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003; 290:2159-2167.
    • (2003) JAMA , vol.290 , pp. 2159-2167
    • Steffes, M.W.1    Chavers, B.M.2    Molitch, M.E.3    Cleary, P.A.4    Lachinc, J.M.5    Genuth, S.6    Nathen, D.M.7
  • 97
    • 75749152972 scopus 로고    scopus 로고
    • Prevention of diabetic nephropathy by tight target control in an Asian population with type 2 diabetes mellitus: A 4-year prospective analysis
    • Tu ST, Chang SJ, Chen JF, Tien KJ, Hsiao JY, Chen HC, et al. Prevention of diabetic nephropathy by tight target control in an Asian population with type 2 diabetes mellitus: a 4-year prospective analysis. Arch Intern Med 2010; 170:155-161.
    • (2010) Arch Intern Med , vol.170 , pp. 155-161
    • Tu, S.T.1    Chang, S.J.2    Chen, J.F.3    Tien, K.J.4    Hsiao, J.Y.5    Chen, H.C.6
  • 98
    • 20044391999 scopus 로고    scopus 로고
    • Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension
    • Pascual JM, Rodilla E, Gonzalez C, Perez-Hoyos S, Redon J. Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension 2005; 45:1125-1130.
    • (2005) Hypertension , vol.45 , pp. 1125-1130
    • Pascual, J.M.1    Rodilla, E.2    Gonzalez, C.3    Perez-Hoyos, S.4    Redon, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.